Result of Extraordinary General Meeting and TVR

RNS Number : 2555T
Glantus Holdings PLC
16 March 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

16 March 2023

 

Glantus Holdings plc

("Glantus" or the "Company")

 

Result of Extraordinary General Meeting and

Total Voting Rights

 

Result of Extraordinary General Meeting

Further to its announcements of 14 February and 17 February 2023 (the "Announcements"), Glantus, the provider of Accounts Payable ("AP") automation and analytics solutions, is pleased to announce that each of the Resolutions put to Shareholders at the Extraordinary General Meeting held earlier today were duly passed.

 

Application has therefore been made for, in aggregate, 13,299,237 Subscription Shares to be admitted to trading on AIM.  As set out in the Circular, the number of Subscription Shares in the capital of the Company to be issued to the Subscribers (to the nearest whole share) is based on the EUR/STG exchange rate at 9 am on 16 March 2023 of 0.8787 divided by the Issue Price.

 

Admission is expected to occur at 8.00 am on 17 March 2023. 

 

This announcement should be read in conjunction with the Announcements and the full text of the Company's circular dated 17 February 2023 ("Circular"), copies of which are available on the Company's website at www.glantus.com. Capitalised terms in this announcement have the same meaning as given in the Circular.

 

Director Participation

Maurice Healy (Chief Executive Officer) subscribed for 3,324,810 Subscription Shares, the resulting shareholding immediately following Admission is detailed below:

 

 

Prior to Admission

Participation in the Subscription

Immediately following Admission

Name

Number of Ordinary Shares

 

Percentage of Existing Ordinary Shares

 

Number of Subscription Shares

Number of Ordinary Shares

Percentage of enlarged Share Capital

Maurice Healy

9,510,433

25.14%

3,324,810

12,835,243

25.10%

 

 

The participation of Maurice Healy, as a Director of the Company, in the Subscription constitutes a related party transaction pursuant to AIM Rule 13 (the "Related Party Transaction"). The independent Directors consider, having consulted with Shore Capital and Corporate Limited ("Shore Capital"), the Company's nominated adviser, that the terms of the Related Party Transaction are fair and reasonable insofar as shareholders of the Company are concerned.

 

Debt Refinancing

As noted in the Circular, the Company has received in writing from BPC an Extension Commitment to extend the repayment date of the €5 million loan repayment due in August 2023 by 12 months. The Company has now satisfied the equity raise condition of the Extension Commitment and is making good progress with finalising the legal agreement. Further updates will be made in due course.

 

Total Voting Rights

Following Admission, the Company will have 51,132,553 Ordinary Shares in issue admitted to trading on AIM. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries

 

Glantus Holdings

 

Maurice Healy, CEO

Diane Gray Smith, Interim CFO

ir@glantus.com

 

+ 353 86 2 677 800 

Shore Capital  

 

Nominated Advisor and Broker

Patrick Castle / John More / Tom Knibbs

 

+ 44 207 408 4090

Yellow Jersey PR

 

Charles Goodwin

Annabelle Wills

 

+44 7747 788 221

Notification of transactions by Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them.

1


Details of the person discharging managerial responsibilities / person closely associated

a)


Name

 

Maurice Healy

2


Reason for the notification

a)


Position/status

 

CEO

b)


Initial notification / Amendment

 

Amendment now the number of subscription shares is fixed

3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)


Name

 

Glantus Holdings Plc

b)


LEI

 

635400B4AX5FLIUCGM84

4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)


Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of €0.001 each in the capital of Glantus Holdings plc ("Ordinary Shares")

 

 

ESVUFR

 

ISIN  IE00BNG2V304

 

 

b)


Nature of the transaction

 

Subscription of new Ordinary Shares

c)


Price(s) and volume(s)

 

 

 

Price

Volume

9.25 pence

3,324,810

 

 

d)


Aggregated information

- Aggregated volume

- Price

 

 

N/A

e)


Date of the transaction

 

17 February 2023

f)


Place of the transaction

 

London Stock Exchange (XLON); AIM Market

 

 

 

About Glantus Holdings plc

Glantus Holdings (AIM: GLAN) Glantus is a global provider of accounts payable automation and analytics solutions. Glantus' mission is to harness technology to drive innovation, unlocking efficiencies in AP to maximise working capital for global enterprise organisations. The award-winning Glantus DataShark Platform connects all AP systems and suppliers on one agile platform, eliminating cost and delivering new revenue streams. We work in tandem with our partners to deliver joint enterprise digital transformation solutions. For more information see glantus.com.

Founded in 2014 and headquartered in Dublin, Glantus has offices in the United States, United Kingdom, Poland and Costa Rica.  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUQPWUPWGWQ
UK 100

Latest directors dealings